User profiles for Daniel G. Tenen

Daniel G Tenen

Cancer Science Institute, National University of Singapore
Verified email at nus.edu.sg
Cited by 54039

[HTML][HTML] EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

…, BE Johnson, MJ Eck, DG Tenen… - … England Journal of …, 2005 - Mass Medical Soc
<p id="p001">Mutations of the epidermal growth factor receptor (<italic>EGFR</italic>) gene
have been identified in specimens from patients with non–small-cell lung cancer who have …

Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak

…, Z Li, L Gan, C He, Z Li, Y Shi, Y Qi, J Yang, DG Tenen… - Cancer discovery, 2020 - AACR
Because this is the first large cohort study on this topic, our report will provide much-needed
information that will benefit patients with cancer globally. As such, we believe it is extremely …

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice

…, GJ Darlington, DG Tenen - Proceedings of the …, 1997 - National Acad Sciences
Transcription factors are master regulatory switches of differentiation, including the
development of specific hematopoietic lineages from stem cells. Here we show that mice with …

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

…, S Schnittger, G Behre, W Hiddemann, DG Tenen - Nature …, 2001 - nature.com
The transcription factor C/EBPα (for CCAAT/enhancer binding protein-α; encoded by the
gene CEBPA) is crucial for the differentiation of granulocytes. Conditional expression of C/EBPα …

[PDF][PDF] Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species

…, S Choi, WG Richards, A De Rienzo, DG Tenen… - Immunity, 2019 - cell.com
Tumor-infiltrating myeloid cells (TIMs) comprise monocytes, macrophages, dendritic cells,
and neutrophils, and have emerged as key regulators of cancer growth. These cells can …

Transcription factors, normal myeloid development, and leukemia

DG Tenen, R Hromas, JD Licht… - Blood, The Journal of …, 1997 - ashpublications.org
Our understanding of myeloid factors has been brought about we will focus on how alteration
of myeloid transcription by a number of different methods. Initially, myeloid factors were …

Disruption of differentiation in human cancer: AML shows the way

DG Tenen - Nature reviews cancer, 2003 - nature.com
Although much is understood about the ways in which transcription factors regulate various
differentiation systems, and one of the hallmarks of many human cancers is a lack of cellular …

Transcription factors in myeloid development: balancing differentiation with transformation

F Rosenbauer, DG Tenen - Nature Reviews Immunology, 2007 - nature.com
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy
of the myeloid lineage. Transcription factors have been shown to be key determinants in the …

[PDF][PDF] Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα

…, JA Lekstrom-Himes, K Akashi, DG Tenen - Immunity, 2004 - cell.com
The transcription factor C/EBPα is required for granulopoiesis and frequently disrupted in
human acute myeloid leukemia (AML). Here, we show disruption of C/EBPα blocks the …

CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors

…, TAO Cheng, DT Scadden, DG Tenen - … and cellular biology, 1998 - Taylor & Francis
The transcription factor CCAAT/enhancer binding protein α (C/EBPα) regulates a number of
myeloid cell-specific genes. To delineate the role of C/EBPα in human granulopoiesis, we …